Comparing time activity curves using the Akaike information criterion

The comparison of curves is a common task in many fields of science. Simply comparing the sums of squares or R(2) is not sufficient, and frequently used tests have many disadvantages. The basic idea of the presented method is turning the problem of comparing curves into a problem of model selection using the corrected Akaike Information Criterion. Here, this straightforward approach is applied for comparing curves using the example of (111)In- and (90)Y-labelled anti-CD66 antibody serum time activity data. As a result it is shown that for the investigated (111)In- and (90)Y-labelled anti-CD66 antibodies, the biokinetics between dosimetry and therapy are different with respect to the contribution of the second, longer half-life component. We advocate the use of the presented method rather than employing less advanced approaches for curve comparison.

[1]  A. Christopoulos,et al.  Fitting Models to Biological Data Using Linear and Nonlinear Regression: A Practical Guide to Curve Fitting , 2004 .

[2]  Pradeep J Nathan,et al.  Small effect of dopamine release and no effect of dopamine depletion on [18F]fallypride binding in healthy humans , 2007, Synapse.

[3]  G. Glatting,et al.  A comparison of the biodistribution and biokinetics of 99mTc-anti-CD66 mAb BW 250/183 and 99mTc-anti-CD45 mAb YTH 24.5 with regard to suitability for myeloablative radioimmunotherapy , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[4]  L. Sachs Angewandte Statistik : Anwendung statistischer Methoden , 1984 .

[5]  M. Rocchetti,et al.  Efficiency of different criteria for selecting pharmacokinetic multiexponential equations , 1991, Biopharmaceutics & drug disposition.

[6]  G. Schwarz Estimating the Dimension of a Model , 1978 .

[7]  G. Glatting,et al.  Model selection for time-activity curves: the corrected Akaike information criterion and the F-test. , 2009, Zeitschrift fur medizinische Physik.

[8]  G. Glatting,et al.  Choosing the optimal fit function: comparison of the Akaike information criterion and the F-test. , 2007, Medical physics.

[9]  Marc J. Mazerolle Mouvements et reproduction des amphibiens en tourbières perturbées , 2004 .

[10]  H. Döhner,et al.  Rhenium 188-labeled anti-CD66 (a, b, c, e) monoclonal antibody to intensify the conditioning regimen prior to stem cell transplantation for patients with high-risk acute myeloid leukemia or myelodysplastic syndrome: results of a phase I-II study. , 2001, Blood.

[11]  G. Glatting,et al.  Treatment of radioactive decay in pharmacokinetic modeling: influence on parameter estimation in cardiac 13N-PET. , 1999, Medical physics.

[12]  I. Pastan,et al.  Imaging and phase I study of 111In- and 90Y-labeled anti-LewisY monoclonal antibody B3. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.